Joseph G. Pressey · Genome-Driven Therapy for Chemotherapy-Resistant Metastatic CDK6-Amplified Osteosarcoma
Follow
Article1 min read·Published Jan 2020Older

Genome-Driven Therapy for Chemotherapy-Resistant Metastatic CDK6-Amplified Osteosarcoma

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2020 · 1 min read

In brief

In brief

Case report or study describing genomic analysis-guided treatment for metastatic osteosarcoma with CDK6 amplification that failed conventional chemotherapy, likely exploring CDK4/6 inhibitor therapy or other targeted approaches.

Written by the GCMD Library team from the article.

Joseph G. Pressey

JCO precision oncology · 2020

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.